Lipopolysaccharide‐neutralizing antibody reduces hepatocyte injury from acute hepatotoxin administration
Mark J. Czaja, Jun Xu, Yue Ju, Elaine Alt, Phyllis Schmiedeberg – 1 May 1994 – Endogenous lipopolysaccharide has been implicated as a cofactor in the hepatocellular injury and death resulting from toxic liver injury. To prevent this lipopolysaccharide‐induced injury and to further understand the mechanism of this effect, an anti‐lipopolysaccharide antibody was administered to rats in which toxic hepatocellular injury was induced. Rats were given the hepatotoxin galactosamine together with an isotypic control antibody B55 or the anti‐lipopolysaccharide antibody E5.